MINOXIDIL

MINOXIDIL was reported 45341 times

These side effects are most commonly reported by patients taking MINOXIDIL:

# Side effect Count
0 ADVERSE DRUG REACTION 8621
1 DRUG INEFFECTIVE 7826
2 ALOPECIA 3835
3 APPLICATION SITE PRURITUS 2979
4 OFF LABEL USE 2293
5 OVERDOSE 1472
6 APPLICATION SITE IRRITATION 1442
7 APPLICATION SITE PAIN 1434
8 HAIR TEXTURE ABNORMAL 1428
9 HEADACHE 1369
10 INCORRECT DOSE ADMINISTERED 1347
11 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1242
12 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1209
13 PRODUCT USE IN UNAPPROVED INDICATION 1206
14 PRURITUS 1032
15 PRODUCT USE ISSUE 930
16 RASH 839
17 APPLICATION SITE DRYNESS 830
18 DIZZINESS 828
19 PRODUCT FORMULATION ISSUE 801
20 APPLICATION SITE ERYTHEMA 788
21 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 769
22 CONDITION AGGRAVATED 750
23 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 730
24 HAIR COLOUR CHANGES 715
25 HYPERSENSITIVITY 691
26 EXPIRED PRODUCT ADMINISTERED 678
27 HAIR GROWTH ABNORMAL 665
28 APPLICATION SITE EXFOLIATION 625
29 APPLICATION SITE RASH 584
30 DANDRUFF 581
31 DRUG ADMINISTERED AT INAPPROPRIATE SITE 500
32 PRODUCT QUALITY ISSUE 487
33 ERYTHEMA 465
34 NAUSEA 443
35 DYSPNOEA 406
36 FATIGUE 402
37 PALPITATIONS 402
38 UNDERDOSE 372
39 DRY SKIN 369
40 THERAPEUTIC RESPONSE UNEXPECTED 365
41 WEIGHT INCREASED 365
42 SKIN EXFOLIATION 345
43 ANXIETY 330
44 CHEST PAIN 330
45 ACCIDENTAL EXPOSURE TO PRODUCT 327
46 HAIR DISORDER 324
47 CHRONIC KIDNEY DISEASE 317
48 SKIN IRRITATION 317
49 HEART RATE INCREASED 307
50 HYPERTENSION 299
51 DEPRESSION 296
52 HYPERTRICHOSIS 295
53 POOR QUALITY PRODUCT ADMINISTERED 292
54 PRODUCT CONTAINER ISSUE 290
55 PAIN 286
56 RENAL FAILURE 282
57 INTENTIONAL PRODUCT MISUSE 272
58 DIARRHOEA 265
59 SWELLING FACE 258
60 PERIPHERAL SWELLING 257
61 APPLICATION SITE SCAB 246
62 CONTRAINDICATED PRODUCT ADMINISTERED 241
63 VOMITING 239
64 ACUTE KIDNEY INJURY 234
65 ERECTILE DYSFUNCTION 227
66 INSOMNIA 226
67 DRUG EFFECT INCOMPLETE 222
68 PARAESTHESIA 222
69 BLOOD PRESSURE INCREASED 214
70 MALAISE 208
71 TRICHORRHEXIS 208
72 END STAGE RENAL DISEASE 205
73 HYPOTENSION 204
74 ARTHRALGIA 197
75 URTICARIA 193
76 ASTHENIA 192
77 DRUG HYPERSENSITIVITY 192
78 SKIN BURNING SENSATION 191
79 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 189
80 ACNE 187
81 OEDEMA PERIPHERAL 180
82 FEELING ABNORMAL 179
83 PRODUCT DOSE OMISSION ISSUE 172
84 SEBORRHOEA 171
85 APPLICATION SITE PAPULES 165
86 VISION BLURRED 160
87 EYE IRRITATION 159
88 APPLICATION SITE ULCER 155
89 HYPOAESTHESIA 153
90 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 152
91 APPLICATION SITE VESICLES 147
92 PERICARDIAL EFFUSION 145
93 APPLICATION SITE ACNE 142
94 BURNING SENSATION 142
95 EYE SWELLING 142
96 NO ADVERSE EVENT 142
97 COUGH 138
98 SKIN DISORDER 132
99 MIGRAINE 131
100 WEIGHT DECREASED 131
101 CARDIAC FAILURE CONGESTIVE 130
102 DRUG ADMINISTRATION ERROR 129
103 CHEST DISCOMFORT 127
104 PNEUMONIA 124
105 THERAPEUTIC PRODUCT EFFECT DECREASED 121
106 LIBIDO DECREASED 120
107 APPLICATION SITE REACTION 117
108 PAIN OF SKIN 117
109 PAIN IN EXTREMITY 116
110 DEATH 115
111 SEXUAL DYSFUNCTION 115
112 SWELLING 115
113 ABDOMINAL PAIN 113
114 PYREXIA 113
115 TACHYCARDIA 111
116 INTENTIONAL PRODUCT USE ISSUE 110
117 ADVERSE EVENT 107
118 MYALGIA 107
119 BACK PAIN 106
120 ATRIAL FIBRILLATION 105
121 APPLICATION SITE BURN 102
122 MYOCARDIAL INFARCTION 99
123 ANAEMIA 97
124 CONSTIPATION 97
125 SKIN DISCOLOURATION 96
126 FALL 95
127 INCORRECT PRODUCT ADMINISTRATION DURATION 95
128 APPLICATION SITE PARAESTHESIA 94
129 JOINT SWELLING 94
130 PSORIASIS 94
131 NEPHROGENIC ANAEMIA 92
132 PRODUCT PHYSICAL CONSISTENCY ISSUE 91
133 LOSS OF LIBIDO 90
134 ABDOMINAL PAIN UPPER 88
135 CEREBROVASCULAR ACCIDENT 88
136 CARDIAC DISORDER 87
137 CONFUSIONAL STATE 87
138 GASTROOESOPHAGEAL REFLUX DISEASE 87
139 SOMNOLENCE 87
140 DECREASED APPETITE 86
141 DRUG EFFECT DECREASED 86
142 PRODUCT STORAGE ERROR 86
143 SUICIDAL IDEATION 86
144 URINARY TRACT INFECTION 86
145 COVID-19 85
146 PRODUCT PACKAGING ISSUE 85
147 BLISTER 84
148 HAEMOGLOBIN DECREASED 84
149 RENAL INJURY 81
150 PLEURAL EFFUSION 80
151 SYNCOPE 79
152 PRODUCT PHYSICAL ISSUE 78
153 SCAB 78
154 MEDICATION RESIDUE PRESENT 77
155 MUSCLE SPASMS 76
156 VERTIGO 76
157 VISUAL IMPAIRMENT 76
158 APPLICATION SITE INFLAMMATION 75
159 RASH PRURITIC 75
160 APPLICATION SITE DISCOMFORT 74
161 BLOOD PRESSURE DECREASED 74
162 RENAL IMPAIRMENT 74
163 HYPERHIDROSIS 73
164 ECZEMA 72
165 HYPERPARATHYROIDISM SECONDARY 71
166 TREMOR 71
167 GAIT DISTURBANCE 70
168 ABDOMINAL DISTENSION 69
169 BLOOD CREATININE INCREASED 69
170 DYSGEUSIA 69
171 EMOTIONAL DISTRESS 68
172 HAIR INJURY 66
173 INJECTION SITE PAIN 66
174 OEDEMA 66
175 APPLICATION SITE HYPERSENSITIVITY 65
176 APPLICATION SITE HAEMORRHAGE 64
177 MUSCULAR WEAKNESS 64
178 FLUID RETENTION 63
179 INFECTION 61
180 TESTICULAR PAIN 60
181 DRUG DOSE OMISSION 59
182 EYE PAIN 59
183 PULMONARY OEDEMA 59
184 BLOOD GLUCOSE INCREASED 58
185 ABDOMINAL DISCOMFORT 57
186 ARRHYTHMIA 57
187 DRUG PRESCRIBING ERROR 57
188 PRODUCT RESIDUE PRESENT 57
189 THERAPEUTIC RESPONSE DECREASED 57
190 DERMATITIS 56
191 FLUSHING 56
192 OCULAR HYPERAEMIA 56
193 STRESS 56
194 BRAIN FOG 55
195 MEMORY IMPAIRMENT 55
196 DEPRESSED MOOD 54
197 DRUG INTERACTION 54
198 HEART RATE IRREGULAR 54
199 RASH ERYTHEMATOUS 54
200 ILLNESS 53
201 GENERAL PHYSICAL HEALTH DETERIORATION 52
202 HOSPITALISATION 52
203 LOSS OF CONSCIOUSNESS 52
204 MEDICATION ERROR 52
205 NASOPHARYNGITIS 52
206 APPLICATION SITE DISCOLOURATION 51
207 APPLICATION SITE SWELLING 51
208 EXPOSURE VIA SKIN CONTACT 51
209 PANIC ATTACK 51
210 SWELLING OF EYELID 51
211 TINNITUS 51
212 COMPLETED SUICIDE 50
213 RASH PAPULAR 50
214 BLOOD PRESSURE FLUCTUATION 49
215 CHILLS 49
216 DERMATITIS CONTACT 49
217 BLOOD POTASSIUM INCREASED 48
218 DEHYDRATION 48
219 DISCOMFORT 48
220 DRUG EFFECT LESS THAN EXPECTED 48
221 DRY EYE 48
222 OROPHARYNGEAL PAIN 48
223 PERIORBITAL SWELLING 48
224 RESTLESS LEGS SYNDROME 48
225 SLEEP DISORDER 48
226 TOXICITY TO VARIOUS AGENTS 48
227 DYSPEPSIA 47
228 NECK PAIN 47
229 PRODUCT ADMINISTRATION ERROR 47
230 EAR SWELLING 46
231 HYPERKALAEMIA 46
232 NASAL CONGESTION 46
233 PRESYNCOPE 46
234 RESTLESSNESS 46
235 SINUSITIS 46
236 ACUTE MYOCARDIAL INFARCTION 45
237 ANHEDONIA 45
238 HOT FLUSH 45
239 SEPSIS 45
240 HAEMORRHAGE 44
241 NEPHROGENIC SYSTEMIC FIBROSIS 44
242 THROMBOSIS 44
243 ANGINA PECTORIS 43
244 BRADYCARDIA 43
245 CARDIO-RESPIRATORY ARREST 43
246 LETHARGY 43
247 PRODUCT PACKAGING QUANTITY ISSUE 43
248 APPLICATION SITE DISCHARGE 42
249 EYE PRURITUS 42
250 GASTROINTESTINAL HAEMORRHAGE 42
251 HAEMORRHOIDS 42
252 SPEECH DISORDER 42
253 ACCIDENTAL OVERDOSE 41
254 EPISTAXIS 41
255 FEELING HOT 41
256 IRRITABILITY 41
257 LEFT VENTRICULAR HYPERTROPHY 40
258 SKIN LESION 40
259 SKIN WRINKLING 40
260 ASTHMA 39
261 CONTUSION 39
262 DERMATITIS ATOPIC 39
263 DRY MOUTH 39
264 HYPERTENSIVE CRISIS 39
265 INCORRECT DRUG ADMINISTRATION DURATION 39
266 NAIL DISCOLOURATION 39
267 PRODUCT COMPLAINT 39
268 PULMONARY HYPERTENSION 39
269 WHITE BLOOD CELL COUNT DECREASED 39
270 APPLICATION SITE WARMTH 38
271 BALANCE DISORDER 38
272 METABOLIC ACIDOSIS 38
273 NEUROPATHY PERIPHERAL 38
274 SKIN REACTION 38
275 CARDIAC ARREST 37
276 CONVULSION 37
277 FEAR 37
278 FLUID OVERLOAD 37
279 INJURY 37
280 LACRIMATION INCREASED 37
281 MUSCULOSKELETAL STIFFNESS 37
282 UNEVALUABLE EVENT 37
283 GASTROINTESTINAL DISORDER 36
284 RASH MACULAR 36
285 RED BLOOD CELL COUNT DECREASED 36
286 RENAL FAILURE ACUTE 36
287 SKIN ULCER 36
288 CARDIAC FAILURE 35
289 CARDIAC TAMPONADE 35
290 LIP SWELLING 35
291 MOBILITY DECREASED 35
292 RHINORRHOEA 35
293 SKIN TIGHTNESS 35
294 THERAPEUTIC PRODUCT EFFECT DELAYED 35
295 BRONCHITIS 34
296 COGNITIVE DISORDER 34
297 HYPERAESTHESIA 34
298 RESPIRATORY FAILURE 34
299 AMNESIA 33
300 DYSPNOEA EXERTIONAL 33
301 PRODUCT USE COMPLAINT 33
302 PRURITUS GENERALISED 33
303 AGITATION 32
304 BLINDNESS 32
305 CENTRAL SEROUS CHORIORETINOPATHY 32
306 DISTURBANCE IN ATTENTION 32
307 GYNAECOMASTIA 32
308 PAPULE 32
309 BASAL CELL CARCINOMA 31
310 CORONARY ARTERY DISEASE 31
311 DISEASE RECURRENCE 31
312 INJECTION SITE ERYTHEMA 31
313 PROTEINURIA 31
314 RENAL DISORDER 31
315 SWOLLEN TONGUE 31
316 TREATMENT NONCOMPLIANCE 31
317 ARTERIOSCLEROSIS 30
318 BLOOD PRESSURE ABNORMAL 30
319 DYSURIA 30
320 HEAD DISCOMFORT 30
321 HEPATIC STEATOSIS 30
322 INFLUENZA 30
323 MOOD ALTERED 30
324 NIGHT SWEATS 30
325 PRODUCT CLOSURE REMOVAL DIFFICULT 30
326 PRODUCT LABEL ISSUE 30
327 SURGERY 30
328 THERAPY CESSATION 30
329 AGGRESSION 29
330 DIABETES MELLITUS 29
331 DIALYSIS 29
332 EXTRA DOSE ADMINISTERED 29
333 FLATULENCE 29
334 PULMONARY EMBOLISM 29
335 STOMATITIS 29
336 THROAT IRRITATION 29
337 THROMBOCYTOPENIA 29
338 ARTHRITIS 28
339 DYSPHAGIA 28
340 FOLLICULITIS 28
341 RENAL CYST 28
342 RENAL FAILURE CHRONIC 28
343 SPINAL OSTEOARTHRITIS 28
344 ANGIOEDEMA 27
345 CEREBRAL INFARCTION 27
346 CONTRAINDICATION TO MEDICAL TREATMENT 27
347 HAEMATOCRIT DECREASED 27
348 LARGE INTESTINE POLYP 27
349 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27
350 MENTAL IMPAIRMENT 27
351 PERIORBITAL OEDEMA 27
352 SEBORRHOEIC DERMATITIS 27
353 ACTINIC KERATOSIS 26
354 DARK CIRCLES UNDER EYES 26
355 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26
356 HEPATIC ENZYME INCREASED 26
357 MOOD SWINGS 26
358 NERVOUSNESS 26
359 PRODUCTIVE COUGH 26
360 TARDIVE DYSKINESIA 26
361 WRONG DRUG ADMINISTERED 26
362 AORTIC VALVE INCOMPETENCE 25
363 BENIGN PROSTATIC HYPERPLASIA 25
364 C-REACTIVE PROTEIN INCREASED 25
365 DYSARTHRIA 25
366 GLYCOSYLATED HAEMOGLOBIN INCREASED 25
367 PENILE SIZE REDUCED 25
368 PENIS DISORDER 25
369 PLATELET COUNT DECREASED 25
370 PRODUCT PRESCRIBING ERROR 25
371 RENAL ARTERY STENOSIS 25
372 ALANINE AMINOTRANSFERASE INCREASED 24
373 ASCITES 24
374 DERMATITIS ALLERGIC 24
375 DISEASE PROGRESSION 24
376 INFLAMMATION 24
377 INJECTION SITE BRUISING 24
378 LYMPHADENOPATHY 24
379 MUSCULOSKELETAL PAIN 24
380 OLIGURIA 24
381 OXYGEN SATURATION DECREASED 24
382 POLLAKIURIA 24
383 PRODUCT SUBSTITUTION ISSUE 24
384 RENAL CYST HAEMORRHAGE 24
385 TREATMENT FAILURE 24
386 UPPER RESPIRATORY TRACT INFECTION 24
387 AORTIC ARTERIOSCLEROSIS 23
388 AORTIC DILATATION 23
389 BLOOD TESTOSTERONE DECREASED 23
390 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23
391 COMPLICATIONS OF TRANSPLANTED KIDNEY 23
392 ECONOMIC PROBLEM 23
393 EYELID OEDEMA 23
394 FACE OEDEMA 23
395 INJECTION SITE SWELLING 23
396 MEAN CELL VOLUME INCREASED 23
397 MENTAL STATUS CHANGES 23
398 PHOTOPHOBIA 23
399 PRODUCT MONITORING ERROR 23
400 SCAR 23
401 SKIN SWELLING 23
402 SPINAL STENOSIS 23
403 SQUAMOUS CELL CARCINOMA OF SKIN 23
404 TUBULOINTERSTITIAL NEPHRITIS 23
405 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22
406 ADVERSE REACTION 22
407 APPLICATION SITE URTICARIA 22
408 BLADDER TRANSITIONAL CELL CARCINOMA 22
409 BLOOD CHOLESTEROL INCREASED 22
410 CAROTID ARTERIOSCLEROSIS 22
411 DELAYED GRAFT FUNCTION 22
412 DIVERTICULUM INTESTINAL 22
413 FUNGAL INFECTION 22
414 GENERALISED OEDEMA 22
415 HEPATOSPLENOMEGALY 22
416 HYPOGLYCAEMIA 22
417 JOINT RANGE OF MOTION DECREASED 22
418 PRESCRIBED OVERDOSE 22
419 RECTAL PROLAPSE 22
420 SENSORY DISTURBANCE 22
421 SKIN HYPERTROPHY 22
422 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22
423 THERAPY INTERRUPTED 22
424 APPLICATION SITE INFECTION 21
425 ASPARTATE AMINOTRANSFERASE INCREASED 21
426 BONE PAIN 21
427 CATARACT 21
428 CELLULITIS 21
429 DIPLOPIA 21
430 DYSPHONIA 21
431 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21
432 INJECTION SITE PRURITUS 21
433 INTENTIONAL DOSE OMISSION 21
434 LAZINESS 21
435 MENTAL DISORDER 21
436 ORTHOSTATIC HYPOTENSION 21
437 PRODUCT PREPARATION ERROR 21
438 SEIZURE 21
439 SKIN INDURATION 21
440 SLEEP APNOEA SYNDROME 21
441 THINKING ABNORMAL 21
442 ATRIOVENTRICULAR BLOCK 20
443 DRUG INTOLERANCE 20
444 EAR PAIN 20
445 GASTRITIS 20
446 HYPOXIA 20
447 INCORRECT PRODUCT STORAGE 20
448 LIVER DISORDER 20
449 OSTEOPOROSIS 20
450 PRODUCT ODOUR ABNORMAL 20
451 REBOUND ACID HYPERSECRETION 20
452 RECTAL HAEMORRHAGE 20
453 SENSITIVE SKIN 20
454 STAPHYLOCOCCAL INFECTION 20
455 ARTHROPATHY 19
456 DISORIENTATION 19
457 EAR DISCOMFORT 19
458 EYE DISORDER 19
459 INTERVERTEBRAL DISC SPACE NARROWING 19
460 JOINT STIFFNESS 19
461 KIDNEY TRANSPLANT REJECTION 19
462 LIBIDO DISORDER 19
463 NEUTROPENIA 19
464 PANCYTOPENIA 19
465 PERICARDITIS 19
466 SKIN HYPERPIGMENTATION 19
467 VASCULAR ANASTOMOTIC HAEMORRHAGE 19
468 VITREOUS FLOATERS 19
469 AGEUSIA 18
470 APHASIA 18
471 BLOOD PRESSURE SYSTOLIC INCREASED 18
472 CHEMICAL BURN 18
473 CONTRAINDICATED DRUG ADMINISTERED 18
474 EAR PRURITUS 18
475 FEELING JITTERY 18
476 GOUT 18
477 HYPOACUSIS 18
478 IMPAIRED QUALITY OF LIFE 18
479 NEOPLASM MALIGNANT 18
480 NEPHROLITHIASIS 18
481 OSTEOARTHRITIS 18
482 PERITONITIS 18
483 VASCULAR COMPRESSION 18
484 WHEEZING 18
485 APPLICATION SITE EROSION 17
486 APPLICATION SITE PUSTULES 17
487 BLOOD SODIUM DECREASED 17
488 BLOOD UREA INCREASED 17
489 HAEMODIALYSIS 17
490 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17
491 NEPHROPATHY 17
492 PAIN IN JAW 17
493 PRODUCT DISPENSING ERROR 17
494 RETCHING 17
495 SECRETION DISCHARGE 17
496 SELF-MEDICATION 17
497 SINUS TACHYCARDIA 17
498 SKIN FISSURES 17
499 TRANSIENT ISCHAEMIC ATTACK 17
500 VENA CAVA INJURY 17
501 VITAMIN D DECREASED 17
502 APPLICATION SITE DERMATITIS 16
503 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16
504 BLOOD GLUCOSE DECREASED 16
505 CARDIOMEGALY 16
506 DEVICE RELATED INFECTION 16
507 DIVERTICULITIS 16
508 EAR INFECTION 16
509 HERPES ZOSTER 16
510 INTELLECTUAL DISABILITY 16
511 INTENTIONAL OVERDOSE 16
512 MADAROSIS 16
513 NODULE 16
514 PANCREATITIS 16
515 POST PROCEDURAL COMPLICATION 16
516 PRODUCT LOT NUMBER ISSUE 16
517 SHOCK 16
518 THERAPY NON-RESPONDER 16
519 TYPE 2 DIABETES MELLITUS 16
520 BLOOD POTASSIUM DECREASED 15
521 CONJUNCTIVITIS 15
522 CROHN^S DISEASE 15
523 DEAFNESS 15
524 EMOTIONAL DISORDER 15
525 HALLUCINATION 15
526 HYPERPARATHYROIDISM 15
527 HYPOKALAEMIA 15
528 INFLUENZA LIKE ILLNESS 15
529 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 15
530 LOCALISED INFECTION 15
531 LUNG DISORDER 15
532 MUSCLE TWITCHING 15
533 NIGHTMARE 15
534 ORAL HERPES 15
535 PERITONITIS BACTERIAL 15
536 PHOTOSENSITIVITY REACTION 15
537 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15
538 PRODUCT DOSE OMISSION 15
539 PRODUCT DOSE OMISSION IN ERROR 15
540 RENAL TRANSPLANT 15
541 RESPIRATORY DISORDER 15
542 RESPIRATORY DISTRESS 15
543 TESTICULAR ATROPHY 15
544 THROAT TIGHTNESS 15
545 UNRESPONSIVE TO STIMULI 15
546 WHITE BLOOD CELL COUNT INCREASED 15
547 ACUTE CORONARY SYNDROME 14
548 BREAST CANCER 14
549 CHOLELITHIASIS 14
550 DRUG EFFECT DELAYED 14
551 DRUG WITHDRAWAL SYNDROME 14
552 EJACULATION DISORDER 14
553 FACIAL PARALYSIS 14
554 FEELING COLD 14
555 GASTROENTERITIS 14
556 GLOMERULAR FILTRATION RATE DECREASED 14
557 HAEMATEMESIS 14
558 HEAD INJURY 14
559 HIP FRACTURE 14
560 HYPERLIPIDAEMIA 14
561 HYPONATRAEMIA 14
562 INITIAL INSOMNIA 14
563 INTRAOCULAR PRESSURE INCREASED 14
564 PERINEAL CYST 14
565 RHEUMATOID ARTHRITIS 14
566 SEMEN VOLUME DECREASED 14
567 SKIN INFECTION 14
568 ABASIA 13
569 ABDOMINAL WALL HAEMORRHAGE 13
570 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13
571 AFFECTIVE DISORDER 13
572 AZOTAEMIA 13
573 BLOOD ALKALINE PHOSPHATASE INCREASED 13
574 BODY TEMPERATURE DECREASED 13
575 BREAST PAIN 13
576 CARDIOMYOPATHY 13
577 CARDIOVASCULAR DISORDER 13
578 CEREBRAL HAEMORRHAGE 13
579 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13
580 COLD SWEAT 13
581 DYSKINESIA 13
582 EJACULATION FAILURE 13
583 EYE INFLAMMATION 13
584 FIBROSIS 13
585 HAEMATOCHEZIA 13
586 HAEMATURIA 13
587 IMMUNODEFICIENCY 13
588 IMPAIRED GASTRIC EMPTYING 13
589 INCORRECT ROUTE OF DRUG ADMINISTRATION 13
590 LIMB DISCOMFORT 13
591 MALIGNANT NEOPLASM PROGRESSION 13
592 MENINGIOMA 13
593 MIXED ANXIETY AND DEPRESSIVE DISORDER 13
594 MYOCARDIAL ISCHAEMIA 13
595 NERVOUS SYSTEM DISORDER 13
596 NEURALGIA 13
597 NIPPLE PAIN 13
598 OCULAR DISCOMFORT 13
599 POOR QUALITY SLEEP 13
600 PRODUCT ADMINISTRATION INTERRUPTED 13
601 SCROTAL OEDEMA 13
602 SKIN FIBROSIS 13
603 SUSPECTED OFF LABEL USE 13
604 TENDONITIS 13
605 THERMAL BURN 13
606 THIRST 13
607 VENTRICULAR TACHYCARDIA 13
608 VIRAL INFECTION 13
609 ACUTE RESPIRATORY FAILURE 12
610 ALOPECIA AREATA 12
611 APATHY 12
612 APPLICATION SITE HYPOAESTHESIA 12
613 BLOOD PRESSURE INADEQUATELY CONTROLLED 12
614 BREAST MASS 12
615 CARDIAC HYPERTROPHY 12
616 COMA 12
617 DEEP VEIN THROMBOSIS 12
618 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12
619 ERUCTATION 12
620 FOETAL EXPOSURE DURING PREGNANCY 12
621 GLAUCOMA 12
622 HAEMATOMA 12
623 HYPOTHYROIDISM 12
624 INJECTION SITE HAEMORRHAGE 12
625 INTESTINAL OBSTRUCTION 12
626 JOINT CONTRACTURE 12
627 KNEE ARTHROPLASTY 12
628 LACTIC ACIDOSIS 12
629 PSYCHOTIC DISORDER 12
630 RENAL TUBULAR NECROSIS 12
631 RHABDOMYOLYSIS 12
632 SINUS DISORDER 12
633 SKIN ODOUR ABNORMAL 12
634 TROPONIN INCREASED 12
635 VISUAL ACUITY REDUCED 12
636 WITHDRAWAL SYNDROME 12
637 ALLERGIC REACTION TO EXCIPIENT 11
638 ANGER 11
639 ANOSMIA 11
640 APPLICATION SITE ALOPECIA 11
641 BLOOD PARATHYROID HORMONE INCREASED 11
642 BONE DISORDER 11
643 CHROMATURIA 11
644 COLITIS ULCERATIVE 11
645 DECREASED ACTIVITY 11
646 DERMAL CYST 11
647 DEVICE ISSUE 11
648 DEVICE MALFUNCTION 11
649 EXPOSURE DURING PREGNANCY 11
650 EXPOSURE VIA EYE CONTACT 11
651 EYE DISCHARGE 11
652 EYELID PTOSIS 11
653 FACIAL PAIN 11
654 HEART RATE DECREASED 11
655 HORMONE LEVEL ABNORMAL 11
656 INFUSION RELATED REACTION 11
657 INTERNATIONAL NORMALISED RATIO INCREASED 11
658 LEUKOCYTOSIS 11
659 MATERNAL EXPOSURE DURING PREGNANCY 11
660 MIDDLE INSOMNIA 11
661 MITRAL VALVE INCOMPETENCE 11
662 MULTI-ORGAN FAILURE 11
663 NEPHROTIC SYNDROME 11
664 PANCREATITIS ACUTE 11
665 POLYURIA 11
666 PRODUCT ADHESION ISSUE 11
667 PSORIATIC ARTHROPATHY 11
668 QUALITY OF LIFE DECREASED 11
669 RESPIRATORY TRACT CONGESTION 11
670 RESPIRATORY TRACT INFECTION 11
671 ROAD TRAFFIC ACCIDENT 11
672 SKIN PLAQUE 11
673 SUBDURAL HAEMATOMA 11
674 ULCER 11
675 WOUND 11
676 WRONG PATIENT RECEIVED MEDICATION 11
677 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11
678 APPLICATION SITE SCAR 10
679 ASPIRATION 10
680 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 10
681 BREAST TENDERNESS 10
682 CHORIORETINOPATHY 10
683 COLITIS 10
684 CYSTITIS 10
685 DEPRESSED LEVEL OF CONSCIOUSNESS 10
686 EJECTION FRACTION DECREASED 10
687 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10
688 GROIN PAIN 10
689 HEMIPARESIS 10
690 HIATUS HERNIA 10
691 HYPERGLYCAEMIA 10
692 HYPERTENSIVE EMERGENCY 10
693 IMPAIRED WORK ABILITY 10
694 INJECTION SITE RASH 10
695 INTENTIONAL DRUG MISUSE 10
696 IRRITABLE BOWEL SYNDROME 10
697 MELAENA 10
698 NASAL DISCOMFORT 10
699 OBESITY 10
700 OCULAR HYPERTENSION 10
701 OSTEOPENIA 10
702 PNEUMONIA HAEMOPHILUS 10
703 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 10
704 RESPIRATORY ARREST 10
705 ROSACEA 10
706 SKIN SENSITISATION 10
707 SKIN TEXTURE ABNORMAL 10
708 SKIN WARM 10
709 SOCIAL AVOIDANT BEHAVIOUR 10
710 STEVENS-JOHNSON SYNDROME 10
711 SUSPECTED COUNTERFEIT PRODUCT 10
712 SYSTEMIC LUPUS ERYTHEMATOSUS 10
713 TASTE DISORDER 10
714 TENSION HEADACHE 10
715 THERAPY PARTIAL RESPONDER 10
716 URINARY RETENTION 10
717 VANISHING BILE DUCT SYNDROME 10
718 VITAMIN D DEFICIENCY 10
719 ABDOMINAL PAIN LOWER 9
720 ABNORMAL BEHAVIOUR 9
721 AMENORRHOEA 9
722 APPLICATION SITE INJURY 9
723 APPLICATION SITE WOUND 9
724 ARTERIOSCLEROSIS CORONARY ARTERY 9
725 ATRIAL FLUTTER 9
726 BLOOD GLUCOSE ABNORMAL 9
727 BLOOD IRON DECREASED 9
728 BLOOD PHOSPHORUS INCREASED 9
729 CARDIAC MURMUR 9
730 COAGULOPATHY 9
731 CRYING 9
732 DEAFNESS UNILATERAL 9
733 DISTRIBUTIVE SHOCK 9
734 DRUG DISPENSING ERROR 9
735 DRY THROAT 9
736 ELECTROCARDIOGRAM ABNORMAL 9
737 EOSINOPHILIA 9
738 EPSTEIN-BARR VIRUS INFECTION 9
739 FEEDING DISORDER 9
740 FORMICATION 9
741 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9
742 GENITAL HYPOAESTHESIA 9
743 HEPATIC FAILURE 9
744 HYPERSOMNIA 9
745 INCREASED APPETITE 9
746 INJECTION SITE URTICARIA 9
747 ISCHAEMIC STROKE 9
748 JAUNDICE 9
749 LEUKOPENIA 9
750 LIQUID PRODUCT PHYSICAL ISSUE 9
751 LOWER LIMB FRACTURE 9
752 MELANOCYTIC NAEVUS 9
753 MUSCLE ATROPHY 9
754 MUSCLE TIGHTNESS 9
755 NERVE INJURY 9
756 NOCTURIA 9
757 PALLOR 9
758 PANIC REACTION 9
759 PERIPHERAL VASCULAR DISORDER 9
760 PORTAL VEIN THROMBOSIS 9
761 PROSTATE CANCER 9
762 PSYCHIATRIC SYMPTOM 9
763 RASH GENERALISED 9
764 RASH PUSTULAR 9
765 SEASONAL ALLERGY 9
766 SEPTIC SHOCK 9
767 SKIN HAEMORRHAGE 9
768 SLUGGISHNESS 9
769 SNEEZING 9
770 TACHYPNOEA 9
771 THERAPY CHANGE 9
772 THYROID DISORDER 9
773 TOOTH FRACTURE 9
774 URINE OUTPUT DECREASED 9
775 VAGINAL HAEMORRHAGE 9
776 VENTRICULAR EXTRASYSTOLES 9
777 WRONG PRODUCT ADMINISTERED 9
778 ACTIVITIES OF DAILY LIVING IMPAIRED 8
779 ANAPHYLACTIC REACTION 8
780 ANDROGENETIC ALOPECIA 8
781 ANGIONEUROTIC OEDEMA 8
782 APPLICATION SITE ECZEMA 8
783 APPLICATION SITE FOLLICULITIS 8
784 APPLICATION SITE NODULE 8
785 BICYTOPENIA 8
786 BLOOD TRIGLYCERIDES INCREASED 8
787 BLOOD URINE PRESENT 8
788 BOWEL MOVEMENT IRREGULARITY 8
789 CORONARY ARTERY OCCLUSION 8
790 DEMENTIA 8
791 DEPERSONALISATION/DEREALISATION DISORDER 8
792 DIABETIC NEUROPATHY 8
793 EATING DISORDER 8
794 ELECTROCARDIOGRAM T WAVE INVERSION 8
795 ENTEROCOCCAL INFECTION 8
796 FAECES DISCOLOURED 8
797 FEAR OF DEATH 8
798 FREQUENT BOWEL MOVEMENTS 8
799 GAIT INABILITY 8
800 GASTRIC DISORDER 8
801 GASTROENTERITIS VIRAL 8
802 GLOMERULONEPHRITIS 8
803 HAEMORRHAGIC STROKE 8
804 HEPATITIS 8
805 HERNIA 8
806 HIRSUTISM 8
807 HYPOAESTHESIA ORAL 8
808 IMPAIRED HEALING 8
809 INTERSTITIAL LUNG DISEASE 8
810 LICHEN PLANOPILARIS 8
811 LOCAL SWELLING 8
812 LUNG INFILTRATION 8
813 METHAEMOGLOBINAEMIA 8
814 MICTURITION URGENCY 8
815 MUSCLE DISORDER 8
816 MUSCULOSKELETAL DISCOMFORT 8
817 MYOCARDITIS 8
818 NEPHROPATHY TOXIC 8
819 NEURODERMATITIS 8
820 NONSPECIFIC REACTION 8
821 ORAL DISCOMFORT 8
822 ORAL DISORDER 8
823 PARAESTHESIA ORAL 8
824 PHARMACEUTICAL PRODUCT COMPLAINT 8
825 PHARYNGEAL SWELLING 8
826 PHOTOPSIA 8
827 POST PROCEDURAL INFECTION 8
828 PROCEDURAL PAIN 8
829 PRODUCT PACKAGING DIFFICULT TO OPEN 8
830 PRODUCT PRESCRIBING ISSUE 8
831 PROSTATIC SPECIFIC ANTIGEN INCREASED 8
832 RASH VESICULAR 8
833 REACTION TO EXCIPIENT 8
834 RENAL TRANSPLANT FAILURE 8
835 RETINAL DETACHMENT 8
836 RIB FRACTURE 8
837 SINUS BRADYCARDIA 8
838 SKIN ATROPHY 8
839 SUICIDAL BEHAVIOUR 8
840 THERAPEUTIC RESPONSE SHORTENED 8
841 TOXIC EPIDERMAL NECROLYSIS 8
842 UMBILICAL HERNIA 8
843 URINARY INCONTINENCE 8
844 VENTRICULAR HYPERTROPHY 8
845 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8
846 ABNORMAL WEIGHT GAIN 7
847 ABORTION INDUCED 7
848 ALOPECIA UNIVERSALIS 7
849 ALTERED STATE OF CONSCIOUSNESS 7
850 ANAL INCONTINENCE 7
851 APHTHOUS ULCER 7
852 APPLICATION SITE PERSPIRATION 7
853 APPLICATION SITE PLAQUE 7
854 ARTERIOVENOUS FISTULA 7
855 ASTHENOPIA 7
856 AURICULAR SWELLING 7
857 BACTERIAL INFECTION 7
858 BLOOD CREATINE PHOSPHOKINASE INCREASED 7
859 BLOOD OESTROGEN INCREASED 7
860 BODY TEMPERATURE INCREASED 7
861 BREAST ENLARGEMENT 7
862 CARDIAC FLUTTER 7
863 CYST 7
864 DENTAL CARIES 7
865 DIABETIC KETOACIDOSIS 7
866 DIZZINESS POSTURAL 7
867 DRUG ADMINISTERED IN WRONG DEVICE 7
868 DRUG RESISTANCE 7
869 ENCEPHALOPATHY 7
870 ERYTHEMA OF EYELID 7
871 ESSENTIAL HYPERTENSION 7
872 EXTRASYSTOLES 7
873 FEMUR FRACTURE 7
874 FURUNCLE 7
875 GASTRIC ULCER 7
876 GASTROINTESTINAL PAIN 7
877 GENITAL DISORDER 7
878 GLOMERULONEPHRITIS ACUTE 7
879 GLOSSODYNIA 7
880 GLUCOSE TOLERANCE IMPAIRED 7
881 HAEMOGLOBIN ABNORMAL 7
882 HALLUCINATION, VISUAL 7
883 HEART RATE ABNORMAL 7
884 HYPERPHOSPHATAEMIA 7
885 HYPOCALCAEMIA 7
886 HYPOTONIA 7
887 INGROWN HAIR 7
888 INSURANCE ISSUE 7
889 INTERNAL HAEMORRHAGE 7
890 INTERVERTEBRAL DISC PROTRUSION 7
891 IRON DEFICIENCY ANAEMIA 7
892 JOINT INJURY 7
893 LACERATION 7
894 LIGAMENT SPRAIN 7
895 LIMB INJURY 7
896 LIP DRY 7
897 MALIGNANT HYPERTENSION 7
898 MALNUTRITION 7
899 MENTAL FATIGUE 7
900 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7
901 MUSCULAR DYSTROPHY 7
902 MYOSITIS 7
903 NEOPLASM PROGRESSION 7
904 OESOPHAGITIS 7
905 ONYCHOCLASIS 7
906 OSTEOMYELITIS 7
907 PANCREATIC CYSTADENOMA 7
908 PAROSMIA 7
909 PELVIC FRACTURE 7
910 PHARYNGEAL OEDEMA 7
911 PLATELET COUNT INCREASED 7
912 PLEUROPERICARDITIS 7
913 PRODUCT AVAILABILITY ISSUE 7
914 PRODUCT LABEL ON WRONG PRODUCT 7
915 PRODUCT PACKAGE ASSOCIATED INJURY 7
916 PRODUCT PREPARATION ISSUE 7
917 PRODUCT TASTE ABNORMAL 7
918 RENAL CANCER 7
919 RENAL PAIN 7
920 SARS-COV-2 ANTIBODY TEST POSITIVE 7
921 SUBARACHNOID HAEMORRHAGE 7
922 TEARFULNESS 7
923 TEMPERATURE INTOLERANCE 7
924 TENDERNESS 7
925 TENDON PAIN 7
926 THROMBOSIS IN DEVICE 7
927 TOOTH LOSS 7
928 TRANSAMINASES INCREASED 7
929 TRICUSPID VALVE INCOMPETENCE 7
930 TYPE 1 DIABETES MELLITUS 7
931 VENOUS THROMBOSIS 7
932 ABDOMINAL TENDERNESS 6
933 ABSCESS 6
934 ACNE CYSTIC 6
935 ACROCHORDON 6
936 ACUTE PULMONARY OEDEMA 6
937 ADRENAL INSUFFICIENCY 6
938 ANAL CYST 6
939 ANKLE FRACTURE 6
940 ANOREXIA 6
941 ANORGASMIA 6
942 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6
943 APPETITE DISORDER 6
944 APPLICATION SITE FISSURE 6
945 ATRIOVENTRICULAR BLOCK COMPLETE 6
946 AUTOIMMUNE DISORDER 6
947 BACTERAEMIA 6
948 BLINDNESS TRANSIENT 6
949 BLOOD CREATINE INCREASED 6
950 BLOOD TEST ABNORMAL 6
951 BONE DENSITY DECREASED 6
952 BRAIN NATRIURETIC PEPTIDE INCREASED 6
953 CANDIDA INFECTION 6
954 CARPAL TUNNEL SYNDROME 6
955 CHEMICAL BURN OF SKIN 6
956 CHOKING 6
957 CONCUSSION 6
958 CONJUNCTIVAL HAEMORRHAGE 6
959 DELIRIUM 6
960 DEVICE BREAKAGE 6
961 DEVICE FAILURE 6
962 DIABETIC RETINOPATHY 6
963 DRUG ABUSE 6
964 DYSPHEMIA 6
965 DYSSTASIA 6
966 ELECTROCARDIOGRAM QT PROLONGED 6
967 ENDOCARDITIS 6
968 EPILEPSY 6
969 EUPHORIC MOOD 6
970 EXTREMITY CONTRACTURE 6
971 EYELIDS PRURITUS 6
972 FEBRILE NEUTROPENIA 6
973 FLANK PAIN 6
974 FOREIGN BODY SENSATION IN EYES 6
975 FUNGAL SKIN INFECTION 6
976 HAEMOLYSIS 6
977 HAEMOLYTIC URAEMIC SYNDROME 6
978 HAEMOPTYSIS 6
979 HEPATIC FUNCTION ABNORMAL 6
980 HEPATOTOXICITY 6
981 HYPERPHAGIA 6
982 HYPERTENSIVE ENCEPHALOPATHY 6
983 HYPERTENSIVE NEPHROPATHY 6
984 HYPERTHYROIDISM 6
985 HYPERVOLAEMIA 6
986 HYPOTRICHOSIS 6
987 ILL-DEFINED DISORDER 6
988 INGUINAL HERNIA 6
989 INJECTION SITE ALOPECIA 6
990 INJECTION SITE REACTION 6
991 INTERVERTEBRAL DISC DEGENERATION 6
992 IRON DEFICIENCY 6
993 KIDNEY INFECTION 6
994 LANGERHANS^ CELL HISTIOCYTOSIS 6
995 LIVER INJURY 6
996 MASS 6
997 MEIBOMIAN GLAND DYSFUNCTION 6
998 MULTIPLE FRACTURES 6
999 MYOCARDIAL NECROSIS 6